These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 41876)
1. Hepatic enzymes of tyrosine metabolism in tyrosinemia II. Goldsmith LA; Thorpe J; Roe CR J Invest Dermatol; 1979 Dec; 73(6):530-2. PubMed ID: 41876 [TBL] [Abstract][Full Text] [Related]
2. Richner-Hanhart syndrome (tyrosinemia type II). Case report and literature review. al-Hemidan AI; al-Hazzaa SA Ophthalmic Genet; 1995 Mar; 16(1):21-6. PubMed ID: 7648039 [TBL] [Abstract][Full Text] [Related]
3. Richner-Hanhart syndrome and tyrosinemia type II. Hunziker N Dermatologica; 1980; 160(3):180-9. PubMed ID: 6446465 [TBL] [Abstract][Full Text] [Related]
4. [A case of Richner-Hanhart syndrome (tyrosinosis with ocular, cutaneous and mental manifestations]. Goddé-Jolly D; Larregue M; Roussat B; Van Effenterre G J Fr Ophtalmol; 1979 Jan; 2(1):23-8. PubMed ID: 34642 [TBL] [Abstract][Full Text] [Related]
5. Painful keratoderma and photophobia: hallmarks of tyrosinemia type II. Rabinowitz LG; Williams LR; Anderson CE; Mazur A; Kaplan P J Pediatr; 1995 Feb; 126(2):266-9. PubMed ID: 7844676 [TBL] [Abstract][Full Text] [Related]
7. Tyrosinemia type II in two cases previously reported as Richner-Hanhart syndrome. Balato N; Cusano F; Lembo G; Santoianni P Dermatologica; 1986; 173(2):66-74. PubMed ID: 2947825 [TBL] [Abstract][Full Text] [Related]
9. Tyrosinemia type II (Richner-Hanhart syndrome): a new mutation in the TAT gene. Culic V; Betz RC; Refke M; Fumic K; Pavelic J Eur J Med Genet; 2011; 54(3):205-8. PubMed ID: 21145993 [TBL] [Abstract][Full Text] [Related]
11. Successful dietary control of tyrosinemia II. Machino H; Miki Y; Kawatsu T; Kida K; Matsuda H J Am Acad Dermatol; 1983 Oct; 9(4):533-9. PubMed ID: 6195199 [TBL] [Abstract][Full Text] [Related]
12. Clinical picture and problems of keratoplasty in Richner-Hanhart syndrome (tyrosinemia type II). Sayar RB; von Domarus D; Schäfer HJ; Beckenkamp G Ophthalmologica; 1988; 197(1):1-6. PubMed ID: 3054681 [TBL] [Abstract][Full Text] [Related]
13. Molecular biology and molecular pathology of a newly described molecular disease--tyrosinemia II (the Richner-Hanhart syndrome). Goldsmith LA Exp Cell Biol; 1978; 46(1-2):96-113. PubMed ID: 23331 [TBL] [Abstract][Full Text] [Related]
14. Familial richner-Hanhart syndrome in Kuwait: twelve-year clinical reassessment by a multidisciplinary approach. el-Badramany MH; Fawzy AR; Farag TI Am J Med Genet; 1995 Oct; 60(5):353-5. PubMed ID: 8546145 [No Abstract] [Full Text] [Related]
16. [4 cases of Richner-Hanhart syndrome (tyrosinemia type II) with neurological symptomatology in a Yugoslav family]. Salamon T; Hrnjica M; Schnyder UW; Lazović O; Softić M; Topić B; Stolić V; Popović N; Cerkez A; Basić V Hautarzt; 1988 Mar; 39(3):149-54. PubMed ID: 2967808 [TBL] [Abstract][Full Text] [Related]
17. Tyrosinemia without liver or renal damage with plantar and palmar keratosis and keratitis (hypertyrosinemia type II). Pelet B; Antener I; Faggioni R; Spahr A; Gautier E Helv Paediatr Acta; 1979 May; 34(2):177-83. PubMed ID: 156708 [TBL] [Abstract][Full Text] [Related]
18. [Tyrosinemia and Richner-Hanhart syndrome (an autosomal recessive hereditary metabolic disease of childhood with bilateral dendritic pseudokeratitis, keratosis palmaris et plantaris and mental deficiency)]. Jaeger W; Gallasch G; Schnyder UW; Lutz P; Schmidt H Ber Zusammenkunft Dtsch Ophthalmol Ges; 1978; (75):649-54. PubMed ID: 154319 [No Abstract] [Full Text] [Related]
19. Point mutations in the tyrosine aminotransferase gene in tyrosinemia type II. Natt E; Kida K; Odievre M; Di Rocco M; Scherer G Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9297-301. PubMed ID: 1357662 [TBL] [Abstract][Full Text] [Related]